Regenxbio (RGNX) Assets (2014 - 2026)
Regenxbio (RGNX) recorded Assets of $386.62 million in Q2 2026, down 33.5% from $581.03 million a year earlier.
Powered by 
Analysis
Regenxbio (RGNX) Assets (2014 - 2026) Analysis & Trends
At the end of FY2025, Regenxbio reported Assets of $453.03 million, down 2.8% from FY2024.
- Annual Assets has declined for four straight years, with a five-year compound annual growth rate of -8.5% (FY2020 to FY2025).
- Across earlier years, Assets came in at $465.99 million in FY2024 (-18.8%), $573.97 million in FY2023 (-31.1%), $833.27 million in FY2022 (-25.2%) and $1.11 billion in FY2021 (+57.3%).
- The Q2 2026 figure is the lowest quarterly Assets since Q2 2018.
- On a year-over-year basis, Assets rose in two of the last seven quarters, with an average decline of 13.1%.
- Peak year-over-year performance for Assets in the last five years was growth of 57.3% in Q4 2021, against a decline of 33.5% in Q2 2026 at the low end.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 201.06 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 135.12 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 129.80 Bn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 122.03 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 115.83 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 95.64 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 49.36 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 201.13 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 27.42 Bn |
| 10 | Regenxbio | 404.61 Mn | -528.48 Mn | - | 386.62 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 386.62 Mn |
| Dec 31, 2025 | 453.03 Mn |
| Sep 30, 2025 | 525.20 Mn |
| Jun 30, 2025 | 581.03 Mn |
| Mar 31, 2025 | 490.93 Mn |
| Dec 31, 2024 | 465.99 Mn |
| Sep 30, 2024 | 519.11 Mn |
| Jun 30, 2024 | 569.38 Mn |
| Mar 31, 2024 | 629.22 Mn |
| Dec 31, 2023 | 573.97 Mn |
| Sep 30, 2023 | 633.79 Mn |
| Jun 30, 2023 | 682.46 Mn |
| Mar 31, 2023 | 747.83 Mn |
| Dec 31, 2022 | 833.27 Mn |
| Sep 30, 2022 | 883.79 Mn |
| Jun 30, 2022 | 953.44 Mn |
| Mar 31, 2022 | 1.03 Bn |
| Dec 31, 2021 | 1.11 Bn |
| Sep 30, 2021 | 800.40 Mn |
| Jun 30, 2021 | 836.40 Mn |
API Access
Regenxbio Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=assets&ticker=RGNX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "assets", "ticker": "RGNX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=assets&ticker=RGNX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();